Does IPTi decrease malaria morbidity but not mortality? Christine Stabell Benn1

The Lancet

Volumn 380, Issue 9846, 2012, Pages 958-960

  Aaby, Peter ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLORPROGUANIL PLUS DAPSONE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; IRON; PLACEBO; PROTOZOON ANTIBODY; PYRIMETHAMINE PLUS SULFADOXINE; RETINOL; ZINC;

ANTIBODY RESPONSE; ANTIMICROBIAL THERAPY; BED NET; CHEMOPROPHYLAXIS; DIPHTHERIA; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; HOSPITAL ADMISSION; HUMAN; IMMUNOMODULATION; MALARIA; MALARIA CONTROL; MORBIDITY; MORTALITY; NOTE; PERTUSSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TETANUS; VACCINATION;

EID: 84866152110     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(12)61184-2     Document Type: Note

References (14)

1. Crawley J, Sismanidis C, Goodman T, Milligan P, WHO Advisory Committee on serological responses to vaccines used in the Expanded Programme on Immunization in infants receiving Intermittent Preventative Treatment for malaria. Effect of intermittent preventive treatment for malaria during infancy on serological responses to measles and other vaccines used in the Expanded Programme on Immunization: results from fi ve randomised controlled trials. Lancet 2012; published online July 30. http://dx.doi.org/10.1016/S0140-6736(12) 607775-2.
2. Aponte JJ, Schellenberg D, Egan A, et al. Effi cacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials. Lancet 2009; 374: 1533-42.
3. WHO. WHO Policy recommendation on Intermittent Preventive Treatment during infancy with sulphadoxine-pyrimethamine (SP-IPTi) for Plasmodium falciparum malaria control in Africa. Geneva: World Health Organization, 2010.
4. Gosling RD, Gesase S, Mosha JF, et al. Protective effi cacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial. Lancet 2009; 374: 1521-32.
5. Chandramohan D, Owusu-Agyei S, Carneiro I, et al. Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana. BMJ 2005; 331: 727-33.
6. Kobbe R, Kreuzberg C, Adjei S, et al. A randomized controlled trial of extended intermittent preventive antimalarial treatment in infants. Clin Infect Dis 2007; 45: 16-25.
7. Schellenberg JR, Maokola W, Shirima K, et al. Cluster-randomized study of intermittent preventive treatment for malaria in infants (IPTi) in southern Tanzania: evaluation of impact on survival. Malar J 2011; 10: 387.
8. Dicko A, Konare M, Traore D, et al. The implementation of malaria intermittent preventive trial treatment with sulphadoxine-pyrimethamine in infants reduced all-cause mortality in the district of Kolokani, Mali: results from a cluster randomized control. Malar J 2012; 11: 73.
9. Dicko A, Toure SO, Traore M, et al. Increase in EPI vaccines coverage after implementation of intermittent preventive treatment of malaria in infant with sulfadoxine-pyrimethamine in the district of Kolokani, Mali: results from a cluster randomized control trial. BMC Public Health 2011; 11: 573.
10. Wilson AL, IPTc Taskforce. A systematic review and meta-analysis of the effi cacy and safety of intermittent preventive treatment of malaria in children (IPTc). PloS One 2011; 6: e16976.
11. WHO IPTi Technical Expert Group. Intermittent preventive antimalarial treatment in infancy. Lancet 2008; 372: 1383-84.
12. Benn CS, Lund S, Fisker A, Jorgensen MJ, Aaby P. Should infant girls receive micronutrient supplements? Int J Epidemiol 2009; 38: 586-90.
13. WHO. Report of the technical consultation on intermittent preventive treatment in infants (IPTi). Technical Expert Group on Preventive Chemotherapy. Geneva, Switzerland, April 23-29, 2009. http://www.who.int/malaria/publications/ atoz/tegconsultiptiapr2009report/en/index.html (accessed July 13, 2012).
14. Neovita Study Author Group, Bahl R, Bhandari N, et al. Effi cacy of early neonatal vitamin A supplementation in reducing mortality during infancy in Ghana, India and Tanzania: study protocol for a randomized controlled trial. Trials 2012; 13: 22.